Sign In
Buy ELDN
$3.81
-0.110 (-2.81%)
At Close: Jun 22, 2026
Eledon Pharmaceuticals, Inc. (ELDN) Q3 2022 Earnings Call Transcript
08:35pm, Monday, 14'th Nov 2022
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Paul Little – Chief Financial Officer David-Alexandre Gros – Chief Ex
Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
04:05pm, Thursday, 22'nd Sep 2022
IRVINE, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that David-Alexandre C. Gros, Chief Executive Officer, will participate
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
08:00am, Monday, 29'th Aug 2022
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor conferenc
Eledon Pharmaceuticals, Inc. (ELDN) CEO David-Alexandre Gros on Q2 2022 Results - Earnings Call Transcript
09:33pm, Thursday, 11'th Aug 2022
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Paul Little - CFO David-Alexandre Gros - CEO Steve Perrin - President and C
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients
09:00am, Monday, 01'st Aug 2022 GlobeNewswire Inc.
IRVINE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:05pm, Friday, 10'th Jun 2022 GlobeNewswire Inc.
IRVINE, Calif., June 10, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development
Penny Stocks To Buy Now? 4 To Watch This Week
01:49pm, Tuesday, 31'st May 2022 PennyStocks
Penny stocks to watch this week.
The post Penny Stocks To Buy Now? 4 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis
10:00am, Tuesday, 31'st May 2022 GlobeNewswire Inc.
IRVINE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development o
Penny Stocks To Buy Now? 3 To Watch This Week
09:49am, Tuesday, 31'st May 2022
Penny stocks to watch this week. The post Penny Stocks To Buy Now?
Eledon Pharmaceuticals, Inc's (ELDN) CEO David-Alexandre Gros on Q1 2022 Results - Earnings Call Transcript
09:01pm, Thursday, 12'th May 2022
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Paul Little – Chief Financial Officer David-Alexandre Gros – Chief Executi
Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
08:05pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
Management to host conference call and webcast at 4:30 p.m. ET Management to host conference call and webcast at 4:30 p.m. ET
Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
04:05pm, Thursday, 05'th May 2022
Management to host conference call and webcast at 4:30 p.m. ET Management to host conference call and webcast at 4:30 p.m. ET
Eledon Pharmaceuticals to Participate in 18th Annual Noble Capital Markets Investor Conference
08:05pm, Monday, 18'th Apr 2022 GlobeNewswire Inc.
IRVINE, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development
Eledon Pharmaceuticals to Participate in 18th Annual Noble Capital Markets Investor Conference
04:05pm, Monday, 18'th Apr 2022
IRVINE, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development o
Eledon to Host Virtual R&D Day on Thursday, April 28, 2022
08:05pm, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development
